yourstate.us
21 CFR 58.33

§ 58.33 Study director.

United States · 21 CFR — Food and Drugs · Status: effective

Get this as JSONEmbed this
Cite this
Citation
21 CFR 58.33, § 58.33 Study director, United States, version 1 as recorded 2026-07-09, yourstate.us, https://yourstate.us/provision/83506
Permanent ID
ys:prov:83506@1
SHA-256
d5b2f1bb34f87e2df3d18bea38bc6972717520c3909c6f2fd48284cd7b9ec0fa

The hash is SHA-256 of this version's text, with every run of whitespace collapsed to a single space and the ends trimmed. The ID always leads back here, and checking it says whether the text you cited is still the current version.

Full text

For each nonclinical laboratory study, a scientist or other professional of appropriate education, training, and experience, or combination thereof, shall be identified as the study director. The study director has overall responsibility for the technical conduct of the study, as well as for the interpretation, analysis, documentation and reporting of results, and represents the single point of study control. The study director shall assure that: (a) The protocol, including any change, is approved as provided by § 58.120 and is followed. (b) All experimental data, including observations of unanticipated responses of the test system are accurately recorded and verified. (c) Unforeseen circumstances that may affect the quality and integrity of the nonclinical laboratory study are noted when they occur, and corrective action is taken and documented. (d) Test systems are as specified in the protocol. (e) All applicable good laboratory practice regulations are followed. (f) All raw data, documentation, protocols, specimens, and final reports are transferred to the archives during or at the close of the study.

Legislative history

This is a federal regulation, adopted through agency rulemaking under the Administrative Procedure Act — not enacted by a recorded vote of Congress.